LVOFX | VEXMX | LVOFX / VEXMX | |
Total Expense Ratio | 1.04 | 0.19 | 547% |
Annual Report Gross Expense Ratio | 1.04 | 0.19 | 547% |
Fund Existence | 18 years | 37 years | - |
Gain YTD | -6.833 | -1.826 | 374% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.09B | 108B | 1% |
Annual Yield % from dividends | 0.11 | 1.08 | 10% |
Returns for 1 year | -6.70 | 10.82 | -62% |
Returns for 3 years | -4.92 | 26.31 | -19% |
Returns for 5 years | 4.46 | 54.37 | 8% |
Returns for 10 years | -10.26 | 108.97 | -9% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ARKG | 23.28 | 1.02 | +4.58% |
ARK Genomic Revolution ETF | |||
MDLV | 26.73 | 0.25 | +0.94% |
Morgan Dempsey Large Cap Value ETF | |||
IYLD | 20.44 | 0.02 | +0.10% |
iShares Morningstar Multi-Asset Inc ETF | |||
PULS | 49.58 | 0.01 | +0.02% |
PGIM Ultra Short Bond ETF | |||
PIZ | 45.13 | -0.01 | -0.01% |
Invesco DW Developed Markets Momt ETF |